The role of Smad3 in mediating mouse hepatic stellate cell activation

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Hepatology

• Publication date

  2001-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/JHEP.2001.25349PMID 11431738
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction of Smad3 with a proximal smad‐binding element of the human α2(I) procollagen gene promoter required for transcriptional activation by TGF‐β

  2000cited by this paper
• Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators

  2000cited by this paper
• Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells.

  2000cited by this paper
• Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF‐β

  2000cited by this paper
• Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.

  2000cited by this paper
• Increased toxin‐induced liver injury and fibrosis in interleukin‐6–deficient mice

  2000cited by this paper
• Transcriptional control by the TGF‐β/Smad signaling system

  2000cited by this paper
• Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.

  2000cited by this paper
• Nuclear factor κB in proliferation, activation, and apoptosis in rat hepatic stellate cells

  2000cited by this paper
• Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts

  2000cited by this paper
• Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury*

  2000cited by this paper
• In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis.

  1999cited by this paper
• TGF-β1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis.

  1999cited by this paper
• Targeted Disruption of Smad3 Reveals an Essential Role in Transforming Growth Factor β-Mediated Signal Transduction

  1999cited by this paper
• Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β1

  1999cited by this paper
• Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice.

  1999cited by this paper
• Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

  1999cited by this paper
• The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo.

  1999cited by this paper
• Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3.

  1999cited by this paper
• TGF‐β induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway

  1999cited by this paper
• Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1.

  1999cited by this paper
• Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β

  1999cited by this paper
• Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators

  1998cited by this paper
• Smad2 role in mesoderm formation, left–right patterning and craniofacial development

  1998cited by this paper
• The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils.

  1998cited by this paper
• Smad3 mutant mice develop metastatic colorectal cancer.

  1998cited by this paper
• Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo.

  1998cited by this paper
• Isoforms and splice variant of transforming growth factor beta-binding protein in rat hepatic stellate cells.

  1998cited by this paper
• Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene

  1998cited by this paper
• Human Smad3 and Smad4 are sequence-specific transcription activators.

  1998cited by this paper
• Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling

  1997cited by this paper
• Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4

  1997cited by this paper
• The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling

  1997cited by this paper
• Evidence for a Role of Rho-like GTPases and Stress-activated Protein Kinase/c-Jun N-terminal Kinase (SAPK/JNK) in Transforming Growth Factor β-mediated Signaling*

  1997cited by this paper
• Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells.

  1997cited by this paper
• Smad4 and FAST-1 in the assembly of activin-responsive factor

  1997cited by this paper
• Transforming growth factor‐β1 induces activation of Ras, Raf‐1, MEK and MAPK in rat hepatic stellate cells

  1997cited by this paper
• Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice.

  1997cited by this paper
• In vivo activation of mitogen-activated protein kinases in rat intestinal neoplasia.

  1997cited by this paper
• TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

  1997cited by this paper
• The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling.

  1997cited by this paper
• Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels

  1997cited by this paper
• Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein

  1997cited by this paper
• Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling.

  1997cited by this paper
• Smad6 inhibits signalling by the TGF-beta superfamily.

  1997cited by this paper
• Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells

  1997cited by this paper
• Receptor-associated Mad homologues synergize as effectors of the TGF-β response

  1996cited by this paper
• Transforming growth factor β1‐regulated gene expression of Ito cells

  1996cited by this paper
• Transforming growth factor beta 1-regulated gene expression of Ito cells.

  1996cited by this paper
• Receptor-associated Mad homologues synergize as effectors of the TGF-beta response.

  1996cited by this paper
• Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways

  1996cited by this paper
• Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

  1996cited by this paper
• A transcriptional partner for MAD proteins in TGF-beta signalling.

  1996cited by this paper
• Sp1 binding activity increases in activated Ito cells

  1995cited by this paper
• Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction

  1995cited by this paper
• Involution of mouse mammary glands in whole organ culture: a model for studying programmed cell death.

  1995cited by this paper
• Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

  1995cited by this paper
• Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation.

  1995cited by this paper
• Mechanism of activation of the TGF-beta receptor.

  1994cited by this paper
• Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo.

  1994cited by this paper
• Mechanism of activation of the TGF-β receptor

  1994cited by this paper
• Stimulation of the collagen α1(I) endogenous gene and transgene in carbon tetrachloride–induced hepatic fibrosis

  1993cited by this paper
• Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.

  1993cited by this paper
• Transforming growth factor-beta in disease: the dark side of tissue repair.

  1992cited by this paper
• Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease

  1992cited by this paper
• The effects of hepatic fibrosis on Ito cell gene expression.

  1992cited by this paper
• Transcriptional mechanisms of type I collagen gene expression are differentially regulated by interleukin-1 beta, tumor necrosis factor alpha, and transforming growth factor beta in Ito cells.

  1992cited by this paper
• Increased transforming growth factor-β1 gene expression in human liver disease

  1992cited by this paper
• Increased transforming growth factor-beta 1 gene expression in human liver disease.

  1992cited by this paper
• Minimal DNA sequences that control the cell lineage-specific expression of the pro alpha 2(I) collagen promoter in transgenic mice

  1992cited by this paper
• Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy.

  1991cited by this paper
• Tissue distribution, quantitation and proliferation kinetics of fat‐storing cells in carbon tetrachloride–injured rat liver

  1991cited by this paper
• Ito‐cell gene expression and collagen regulation

  1990cited by this paper
• Expression of the gene of the α-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells

  1990cited by this paper
• Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis.

  1990cited by this paper
• In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis

  1989cited by this paper
• Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta.

  1989cited by this paper
• Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells.

  1989cited by this paper
• In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: Evidence for predominant expression in nonparenchymal liver cells

  1989cited by this paper
• Transforming growth factor β responsiveness is modulated by the extracellular collagen matrix during hepatic ito cell culture

  1988cited by this paper
• Collagen production in fat-storing cells after carbon tetrachloride intoxication in the rat. Immunoelectron microscopic observation of type I, type III collagens, and prolyl hydroxylase.

  1988cited by this paper
• Characterization of desmin‐positive rat liver sinusoidal cells

  1987cited by this paper
• Expression and secretion of type beta transforming growth factor by activated human macrophages.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells.

  1984cited by this paper
• Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

  1983cited by this paper

• Suppressing MASH fibrotic progression by blocking succinate-GPR91 signaling in hepatic stellate cells.

  2025cites this paper
• Set up of a human 3D liver multicellular model for chemical high-throughput toxic hazard assessment

  2025cites this paper
• Metabolites involvement in the growth and spread of liver cancer

  2025cites this paper
• Purinergic Signaling in Non-Parenchymal Liver Cells

  2024cites this paper
• Mammalian cleavage factor 25 targets KLF14 to inhibit hepatic stellate cell activation and liver fibrosis.

  2023cites this paper
• Ablation of DGKα facilitates α‐smooth muscle actin expression via the Smad and PKCδ signaling pathways during the acute phase of CCl4 ‐induced hepatic injury

  2023cites this paper
• MFAP2 promotes HSCs activation through FBN1/TGF‐β/Smad3 pathway

  2023cites this paper
• Cellular heterogeneity and plasticity during NAFLD progression

  2023cites this paper
• Impaired reciprocal regulation between SIRT6 and TGF‐β signaling in fatty liver

  2022cites this paper
• Effects of Ion-Transporting Proteins on the Digestive System Under Hypoxia

  2022cites this paper
• The role of green peas protein hydrolysate in TGF/ SMAD signaling to prevent renal fibrosis

  2022cites this paper
• From Inflammation to Fibrosis: Novel Insights into the Roles of High Mobility Group Protein Box 1 in Schistosome-Induced Liver Damage

  2022cites this paper
• From hair to liver: emerging application of hair follicle mesenchymal stem cell transplantation reverses liver cirrhosis by blocking the TGF-β/Smad signaling pathway to inhibit pathological HSC activation

  2022cites this paper
• Layered Double Hydroxides-Loaded Sorafenib Inhibit Hepatic Stellate Cells Proliferation and Activation In Vitro and Reduce Fibrosis In Vivo

  2022cites this paper
• Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin

  2022cites this paper
• Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis

  2021cites this paper
• Depletion of serotonin relieves concanavalin A-induced liver fibrosis in mice by inhibiting inflammation, oxidative stress, and TGF-β1/Smads signaling pathway.

  2021cites this paper
• (Pro)renin Receptor Knockdown Attenuates Liver Fibrosis Through Inactivation of ERK/TGF-β1/SMAD3 Pathway

  2021cites this paper
• Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-β1/Smad and EMT pathways.

  2020cites this paper
• 11β-hydroxysteroid dehydrogenase-1 is associated with the activation of hepatic stellate cells in the development of hepatic fibrosis

  2020cites this paper
• Diverse origins and activation of fibroblasts in cardiac fibrosis.

  2020cites this paper
• Molecular and cellular mechanisms of liver fibrosis and its regression

  2020cites this paper
• The effects of inhibiting the activation of hepatic stellate cells by lignan components from the fruits of Schisandra chinensis and the mechanism of schisanhenol

  2020cites this paper
• Graptopetalum paraguayense Inhibits Liver Fibrosis by Blocking TGF-β Signaling In Vivo and In Vitro

  2019cites this paper
• Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate Cells.

  2019cites this paper
• The Evolving Landscape of Liver Cirrhosis Management

  2019cites this paper
• Antifibrotic Therapy for Liver Cirrhosis

  2019cites this paper
• Magnesium and liver disease.

  2019cites this paper
• Sulforaphane inhibits the activation of hepatic stellate cell by miRNA-423-5p targeting suppressor of fused

  2019cites this paper
• Signal Transduction in Disease

  2019cites this paper
• The Impact of a Nitric Oxide Synthase Inhibitor (L-NAME) on Ischemia–Reperfusion Injury of Cholestatic Livers by Pringle Maneuver and Liver Resection after Bile Duct Ligation in Rats

  2019cites this paper
• Amendment history : Corrigendum ( April 2005 ) Liver fibrosis Ramón Bataller

  2018cites this paper
• Molecular and tissue alterations of collagens in fibrosis.

  2018cites this paper
• Food components with antifibrotic activity and implications in prevention of liver disease.

  2018cites this paper
• Carnosic acid prevents COL1A2 transcription through the reduction of Smad3 acetylation via the AMPK&agr;1/SIRT1 pathway

  2018cites this paper
• Utilizing Combinatorial Screening Platforms and Modelling Techniques to Predict Optimal Design Conditions for 3D Mesenchymal Stromal Cell Based Heart Valve Tissue Engineering

  2018cites this paper
• SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice

  2018cites this paper
• Efficacy of ALK 5 inhibition in myelofibrosis

  2017cites this paper
• Current Understanding of Stem Cell and Secretome Therapies in Liver Diseases

  2017cites this paper
• Suv39h2 deficiency ameliorates diet-induced steatosis in mice.

  2017cites this paper
• Knockdown of HIPK2 attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.

  2017cites this paper
• Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis

  2017influential citation
• Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease

  2017cites this paper
• Modulation of TGF‐&bgr;/Smad and ERK signaling pathways mediates the anti‐fibrotic effect of mirtazapine in mice

  2017cites this paper
• Epigenetics in Liver Fibrosis

  2017cites this paper
• Prevention of TGF-β-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation

  2017cites this paper
• Efficacy of ALK5 inhibition in myelofibrosis.

  2017cites this paper
• EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis

  2016cites this paper
• Clonorchis sinensis lysophospholipase inhibits TGF-β1-induced expression of pro-fibrogenic genes through attenuating the activations of Smad3, JNK2, and ERK1/2 in hepatic stellate cell line LX-2

  2016influential citation
• Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis.

  2016cites this paper
• Effects of Complementary Combination Therapy of Korean Red Ginseng and Antiviral Agents in Chronic Hepatitis B

  2016cites this paper
• Transforming Growth Factor-ß and Connective Tissue Growth Factor

  2016cites this paper
• Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagy

  2016cites this paper
• Targeting tissue inhibitor of metalloproteinase 1 / 2 using a shRNA lentiviral system offers a novel treatment strategy against hepatic fibrosis

  2016cites this paper
• Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis

  2016cites this paper
• MiR-10a improves hepatic fibrosis by regulating the TGFβl/Smads signal transduction pathway

  2016cites this paper
• Tumor-Suppressive and Tumor-Promoting Role of Tgf-β in Hepatocellular Carcinoma

  2016cites this paper
• of corneal alkali burn in mice on the healing process γ Effect of overexpression of ppar

  2016cites this paper
• Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses

  2016cites this paper
• Cellular Mechanisms of Tissue Fibrosis Role of Smad 3 in platelet-derived growth factor-C-induced liver fibrosis

  2016cites this paper
• The rationale for targeting TGF‐β in chronic liver diseases

  2016cites this paper
• Protective effects of S-adenosylmethionine against CCl4- and ethanol-induced experimental hepatic fibrosis

  2016cites this paper
• A new fluorescence-based optical imaging method to non-invasively monitor hepatic myofibroblasts in vivo

  2016cites this paper
• Myocardin-related transcription factor A (MRTF-A) plays an essential role in hepatic stellate cell activation by epigenetically modulating TGF-β signaling.

  2016cites this paper
• Involvement of TGF-β1/Smad3 Signaling in Carbon Tetrachloride-Induced Acute Liver Injury in Mice

  2016cites this paper
• Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice.

  2016cites this paper
• Angiogenic factor with G patch and FHA domains 1 (Aggf1) regulates liver fibrosis by modulating TGF-β signaling.

  2016cites this paper
• Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice

  2015cites this paper
• Ethyl acetate fraction of Amomum xanthioides improves bile duct ligation-induced liver fibrosis of rat model via modulation of pro-fibrogenic cytokines

  2015cites this paper
• Hepatic fibrosis and cirrhosis

  2015cites this paper
• Pathophysiology of Portal Hypertension

  2015cites this paper
• Receptor channel TRPC6 orchestrate the activation of human hepatic stellate cell under hypoxia condition.

  2015cites this paper
• Mechanical and Matrix Regulation of Valvular Fibrosis

  2015cites this paper
• Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury.

  2015cites this paper
• Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis

  2015cites this paper
• Title Current Status of Herbal Medicines in Chronic Liver Disease Therapy : The Biological Effects , Molecular Targets and Future Prospects

  2015cites this paper
• Effects of 18α-glycyrrhizin on TGF-β1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis.

  2015influential citation
• MKL1 is an epigenetic modulator of TGF-β induced fibrogenesis.

  2015cites this paper
• Novel perspectives on the origins of the hepatic myofibroblasts

  2015cites this paper
• Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects

  2015cites this paper
• Cell–Substrate Interactions

  2015cites this paper
• The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis.

  2015cites this paper
• Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice

  2015cites this paper
• Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis

  2015cites this paper
• Suppression of the TGF-β/Smad signaling pathway and inhibition of hepatic stellate cell proliferation play a role in the hepatoprotective effects of curcumin against alcohol-induced hepatic fibrosis.

  2014cites this paper
• TGF-β1-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-β1/Smad pathway.

  2014cites this paper
• Smad3 Deficiency Counteracts Hepatocyte Apoptosis and Portal Fibrogenesis Induced By Bile Duct Ligation

  2014cites this paper
• Endoglin in liver fibrogenesis: Bridging basic science and clinical practice.

  2014cites this paper
• Xuefuzhuyu decoction inhibition of angiogenesis attenuates liver fibrosis induced by CCl₄ in mice.

  2014cites this paper
• Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride‐induced liver fibrosis

  2014cites this paper
• Smad3 signaling in the regenerating liver: implications for the regulation of IL‐6 expression

  2014cites this paper
• The role of mRNA translational regulation in models of hepatotoxicity

  2014cites this paper
• Role of NADPH Oxidases in Liver Fibrosis

  2014cites this paper
• Phenotypic Changes in Hepatic Stellate Cells in Response to Toxic Liver Injury

  2014cites this paper
• Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF‐β1/Smad2/3 signalling

  2014cites this paper
• Protection and Reversal of Hepatic Fibrosis by Polyphenols

  2014cites this paper
• Extracellular Matrix and Liver Disease

  2014cites this paper
• 3,3′‐Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR‐21 expression

  2013cites this paper
• TGF-β in Human Disease

  2013cites this paper
• Original Article Inhibitory effect of bone morphogenetic protein-7 on hepatic fibrosis in rats

  2013cites this paper